Target control infusion propofol

Phase 3Small molecule

IInstitute of Liver and Biliary Sciences, India

Target control infusion propofol is one of 44 small molecule programs targeting Liver Transplant. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Liver TransplantRecruiting

Liver TransplantPhase 3

Recruiting

Competition

Competitive Landscape

95 competitors in Liver Transplant

#DrugCompanyPhaseTrials

Giapreza

LLa Jolla Pharmaceutical Company

Phase 3

1 2

Prothrombin Complex Concentrate

CSL Behring

Phase 3

1 3

Darbepoetin

Bayer

Phase 3

1 4

Tacrolimus Pill

EEdward Geissler

Phase 3

1 5

Target control infusion propofol

IInstitute of Liver and Biliary Sciences, India

Phase 3

1 6

Lenvima

Eisai

Preclinical

2 7

Octreotide

Johnson & Johnson

Preclinical

2 8

Beyfortus

BeiGene

Preclinical

1 9

Prostigmin

Merck & Co.

Preclinical

1 10

Myfortic

Novartis

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Liver Transplant1 trial

Effect of TCI Propofol on Liver Transplant (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients.

Recruiting·IInstitute of Liver and Biliary Sciences, India·Phase 2/3·NCT06418893·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Target control infusion propofol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Target control infusion propofol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Target control infusion propofol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Institute of Liver and Biliary Sciences, India company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: IInstitute of Liver and Biliary Sciences, India

Target control infusion propofol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Liver Transplant1 trial

References

Drug Info

Quick Facts

Related News